PMX

Technology with heart, innovation with soul
PMX is transforming brain medicine with AI

Opening a new era of medicine with the possibilities data discovers within the mind
From emotional well-being to brain signals, we are building a world where AI understands people, and people trust AI

Deep learning-based brain MRI AI analysis
Phenotype AI that understands your mind
Heterogeneous medical data AI platform

Technology with heart,
transforming medicine with AI

From emotional well-being to brain signals
we are building a world where AI understands people,
and people trust AI

Deep learning-based brain MRI AI analysis
Phenotype AI that understands your mind
Heterogeneous medical data AI platform

This is how PMX
is changing the world

From AI that reads the mind
to advanced medical technology
that automatically analyzes the brain
transforming medicine with AI

The future of medicine where technology meets humanity —

our AI does not replace clinical expertise;
it strengthens it, supports physician decision-making,
and helps deliver the best possible outcomes for patients

Backed by proven technology and clinical experience,
we develop AI solutions that physicians and patients can trust

Save time
and raise accuracy
like magic

Validated with world-leading medical institutions,
approved by regulatory agencies at home and abroad,
and proven in real clinical practice by physicians —
trusted medical AI technology

AI becomes a reliable partner for clinicians,
delivering better outcomes for patients
and more precise diagnostic tools for physicians —
setting a new standard for medical innovation

Born from compassion,
AI for people,
healing through technology

Every AI technology we build is designed around
the most precious value of all: people.

From inCare, which cares for mental health around the clock,
to MRI AI agents that precisely analyze brain health,
and MediOMx, which unifies all medical imaging —
each solution advances toward one goal:
improving patients' quality of life

From AI that reads the mind
to advanced medical technology
that automatically analyzes the brain
transforming medicine with AI

Our AI does not replace clinical expertise;
it strengthens it and supports physician decision-making
Backed by proven technology and clinical experience,
we develop solutions that physicians and patients can trust

Save time
and raise accuracy
like magic

Validated with world-leading medical institutions,
approved by regulatory agencies at home and abroad,
and proven in real clinical practice by physicians —
trusted medical AI technology

Born from compassion,
AI for people,
healing through technology

From inCare, which cares for mental health around the clock,
to MRI AI agents that precisely analyze brain health,
and MediOMx, which unifies all medical data —
each solution advances toward one goal:
improving patients' quality of life

We work with partners
and investors like these

How we keep
advancing forward

PMX full rebrand and website relaunch

August 2025

AI server room expansion and relocation

July 2025

MinOMx rebranded to inCare; B2C beta launch

June 2025

MinOMx beta app development

February 2025

MediOMx medical imaging AI receives U.S. FDA approval

2024

Partnership with GD Imaging Ltd. for MSK AI solutions

2023

AI technology partnership with InMed Prognostics

2023

Partnership with Lightbox AI for ChestOMX solution

2023

Clinical collaboration with Samsung Medical Center on sleep behavior disorder brain MRI

2023

First exhibition at RSNA

2021

Selected for U.S. Newchip Accelerator Program

2021

Established PMX U.S. subsidiary

2021

Selected for TIPS: AI-based integrated digital medical solution for degenerative brain MRI

2021

Completed 19 trademark filings including BrainOMx

2021

Filed 20 patents for automated medical image analysis and diagnosis

2021

Microsoft Start-up Program

2021

Obtained GMP for medical imaging equipment software

2021

Founded Finomax Co., Ltd.

2020

Patent filed: lesion interpretation method and apparatus

2020

Selected for WINGS: embedded AI hardware for viral pneumonia diagnosis

2020

COVID-19 AI research MOU with Vatech, Myongji Hospital, and PMX

2020

Selected for Korea Credit Guarantee Fund Start-up NEST

2020

PMX full rebrand and website relaunch

August 2025

AI server room expansion and relocation

July 2025

MinOMx rebranded to inCare; B2C beta launch

June 2025

MinOMx beta app development

February 2025

MediOMx medical imaging AI receives U.S. FDA approval

2024

Partnership with GD Imaging Ltd. for MSK AI solutions

2023

AI technology partnership with InMed Prognostics

2023

Partnership with Lightbox AI for ChestOMX solution

2023

Clinical collaboration with Samsung Medical Center on sleep behavior disorder brain MRI

2023

First exhibition at RSNA

2021

Selected for U.S. Newchip Accelerator Program

2021

Established PMX U.S. subsidiary

2021

Selected for TIPS: AI-based integrated digital medical solution for degenerative brain MRI

2021

Completed 19 trademark filings including BrainOMx

2021

Filed 20 patents for automated medical image analysis and diagnosis

2021

Microsoft Start-up Program

2021

Obtained GMP for medical imaging equipment software

2021

Founded Finomax Co., Ltd.

2020

Patent filed: lesion interpretation method and apparatus

2020

Selected for WINGS: embedded AI hardware for viral pneumonia diagnosis

2020

COVID-19 AI research MOU with Vatech, Myongji Hospital, and PMX

2020

Selected for Korea Credit Guarantee Fund Start-up NEST

2020

This is how PMXis changing the world

This is how PMX
is changing the world